Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease

Cited by papers we hold 23

• Selective reduction of astrocyte apoE3 and apoE4 strongly reduces Aβ accumulation and plaque-related pathology in a mouse model of amyloidosis · 2022
  No notice
• The amyloid plaque proteome in early onset Alzheimer’s disease and Down syndrome · 2022
  No notice
• APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer’s disease pathology and brain diseases · 2022
  No notice
• The Evolving Landscape of Exosomes in Neurodegenerative Diseases: Exosomes Characteristics and a Promising Role in Early Diagnosis · 2021
  No notice
• Phospholipids of APOE lipoproteins activate microglia in an isoform-specific manner in preclinical models of Alzheimer’s disease · 2021
  No notice
• Astrocytes in Alzheimer’s Disease: Pathological Significance and Molecular Pathways · 2021
  No notice
• Lipids and Alzheimer’s Disease · 2020
  No notice
• Apolipoprotein E4, inhibitory network dysfunction, and Alzheimer’s disease · 2019
  No notice
• Neuroinflammation as a Common Feature of Neurodegenerative Disorders · 2019
  No notice
• Invited Review: APOE at the interface of inflammation, neurodegeneration and pathological protein spread in Alzheimer's disease · 2018
  No notice
• The Role of APOE and TREM2 in Alzheimer′s Disease—Current Understanding and Perspectives · 2018
  No notice
• The Endosomal–Lysosomal Pathway Is Dysregulated by APOE4 Expression in Vivo · 2017
  No notice
• Neuronal hyperactivity due to loss of inhibitory tone in APOE4 mice lacking Alzheimer’s disease-like pathology · 2017
  No notice
• Clearance of cerebral Aβ in Alzheimer’s disease: reassessing the role of microglia and monocytes · 2017
  No notice
• The amyloid hypothesis of Alzheimer's disease at 25 years · 2016
  No notice
• HMGB1, a pathogenic molecule that induces neurite degeneration via TLR4-MARCKS, is a potential therapeutic target for Alzheimer’s disease · 2016
  No notice
• Opposing effects of viral mediated brain expression of apolipoprotein E2 (apoE2) and apoE4 on apoE lipidation and Aβ metabolism in apoE4-targeted replacement mice · 2015
  No notice
• Oxidized cholesterol as the driving force behind the development of Alzheimer’s disease · 2015
  No notice
• Impaired vascular-mediated clearance of brain amyloid beta in Alzheimer’s disease: the role, regulation and restoration of LRP1 · 2015
  No notice
• Oxidative Stress and Metabolic Syndrome: Cause or Consequence of Alzheimer's Disease? · 2014
  No notice

and 3 more

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.